Geneos Wealth Management’s Henry Schein HSIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.3K Sell
384
-508
-57% -$39.2K ﹤0.01% 1645
2025
Q4
$67.4K Hold
892
﹤0.01% 1286
2025
Q3
$59.2K Sell
892
-80
-8% -$5.54K ﹤0.01% 1316
2025
Q2
$71K Sell
972
-880
-48% -$60.6K ﹤0.01% 1402
2025
Q1
$127K Buy
1,852
+960
+108% +$70.9K ﹤0.01% 1437
2024
Q4
$61.7K Sell
892
-2
-0.2% -$144 ﹤0.01% 1241
2024
Q3
$65.2K Buy
894
+2
+0.2% +$139 ﹤0.01% 1103
2024
Q2
$57.2K Hold
892
﹤0.01% 1029
2024
Q1
$67.4K Hold
892
﹤0.01% 969
2023
Q4
$67.5K Hold
892
﹤0.01% 968
2023
Q3
$66.2K Hold
892
﹤0.01% 994
2023
Q2
$72.3K Hold
892
﹤0.01% 968
2023
Q1
$72.7K Hold
892
﹤0.01% 948
2022
Q4
$71.2K Hold
892
﹤0.01% 924
2022
Q3
$58K Sell
892
-140
-14% -$10.4K ﹤0.01% 981
2022
Q2
$79K Sell
1,032
-7
-0.7% -$587 ﹤0.01% 1099
2022
Q1
$90K Buy
1,039
+7
+0.7% +$570 ﹤0.01% 1132
2021
Q4
$80K Hold
1,032
﹤0.01% 1256
2021
Q3
$81K Hold
1,032
﹤0.01% 1254
2021
Q2
$78K Sell
1,032
-39
-4% -$2.94K ﹤0.01% 1263
2021
Q1
$77K Hold
1,071
﹤0.01% 1406
2020
Q4
$70K Buy
1,071
+39
+4% +$2.52K ﹤0.01% 1296
2020
Q3
$60K Hold
1,032
﹤0.01% 1171
2020
Q2
$58K Buy
1,032
+115
+13% +$6.43K ﹤0.01% 1152
2020
Q1
$45K Sell
917
-102
-10% -$6.47K ﹤0.01% 1155
2019
Q4
$67K Buy
1,019
+127
+14% +$8.4K ﹤0.01% 1113
2019
Q3
$55K Hold
892
﹤0.01% 1134
2019
Q2
$62K Sell
892
-38
-4% -$2.51K ﹤0.01% 1091
2019
Q1
$55K Sell
930
-256
-22% -$15.4K ﹤0.01% 1090
2018
Q4
$72K Hold
1,186
0.01% 949
2018
Q3
$79K Buy
1,186
+1,138
+2,371% +$70.9K 0.01% 975
2018
Q2
$2K Sell
48
-1,138
-96% -$64.1K ﹤0.01% 2107
2018
Q1
$62K Hold
1,186
0.01% 916
2017
Q4
$64K Hold
1,186
0.01% 901
2017
Q3
$76K Sell
1,186
-28
-2% -$1.91K 0.01% 795
2017
Q2
$87K Hold
1,214
0.01% 729
2017
Q1
$80K Hold
1,214
0.01% 726
2016
Q4
$72K Hold
1,214
0.01% 704
2016
Q3
$77K Hold
1,214
0.01% 664
2016
Q2
$84K Hold
1,214
0.01% 637
2016
Q1
$82K Buy
+1,214
New +$75.8K 0.01% 643

Other funds holding HSIC

Geneos Wealth Management's HSIC Position: Q1 2026 in Review

Geneos Wealth Management reduced its Henry Schein (HSIC) stake by 57% in Q1 2026, selling an estimated $39.2K and leaving 384 shares worth $28.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1645.

Geneos Wealth Management first reported a position in HSIC in Q1 2016 and has held it in 41 quarters since. The position peaked at $127K in Q1 2025. 558 funds tracked by Wall St. Rank hold HSIC as of Q1 2026.

  • Geneos Wealth Management held 384 shares of Henry Schein worth $28.3K as of Q1 2026.
  • Geneos Wealth Management sold 508 Henry Schein shares in Q1 2026, an estimated $39.2K.
  • Henry Schein made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1645 holding.
  • Geneos Wealth Management first reported a position in Henry Schein in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's Henry Schein position peaked at $127K in Q1 2025.
  • 558 funds tracked by Wall St. Rank held Henry Schein as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.